Publication | Closed Access

Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion

Indefinite SurvivalCell TherapyTransplantationAutoimmune DiseaseT-regulatory CellImmunologyAutoimmunityImmunomodulationCell TransplantationDermatologyVascularized Skin AllograftsMedicineCell BiologyGraft RejectionAlloantigen-pulsed Dendritic Cells